A research data repository that combines millions of de-identified claims and electronic medical records would allow healthcare organizations to conduct evidence-based research on the effectiveness of ...

“Are we going to throw expensive treatment at someone who is going to die anyway? How do we get people to accept that more isn’t always better, the newest treatment isn’t always better?” Those were ...

Comparative effectiveness research has been the target of recurrent criticism in some political circles, with opponents claiming it’s the “gateway to rationing” or it encourages “cookbook medicine.” ...

If there was one place research should be easy to perform, it’s on a disease that’s incredibly common. Further, if there are two generally-accepted strategies to treating symptomatic patients with ...

Ellen-Marie Whelan discusses why we need evidence-based health care, how it will improve health, and how we can promote it. The positions of American Progress, and our policy experts, are independent, ...

The research results must avoid creating unintended access barriers, coverage denials, or arbitrary dollar thresholds that can arise through centralized cost effectiveness determinations. By focusing ...

It is clear to all informed persons that the nation needs better evidence of what works in health care, and this has propelled comparative effectiveness research (CER) policy developments of late.

Groundbreaking comparative study reveals best treatment for diabetes - Findings point to a paradigm shift in diabetes care, scientists say ...

The objectives of this article are (1) to examine the similarities and differences between comparative effectiveness research (CER) and evidence-based medicine (EBM); (2) to describe the implications ...

That’s her hope for her current multisite randomized controlled trial, which will test the effects of a low glycemic load diet and calorie restriction in people with multiple sclerosis (MS). She and ...

The Patient-Centered Outcomes Research Institute (PCORI) today announced the approval of funding awards totaling more than $165 million for new patient-centered comparative clinical effectiveness ...